J1105 HCPCS code: Dexmedetomidine, oral, 1 mcg
J1105 is the HCPCS Level II code for dexmedetomidine, oral, 1 mcg. Its Medicare coverage code is I (Not payable by Medicare): Medicare does not pay separately under this code; another code applies. The NCCI unit limit is 360 per day on DME suppliers.
Code details
| Field | Value |
|---|---|
| Section | J codes — Drugs administered other than oral method |
| Coverage code | I — Not payable by Medicare |
| Pricing indicator | 51 — Drug or biological (priced per ASP/average sales price rules) |
| BETOS category | O1E — Other drugs |
| Added | 2024-01-01 |
| Last action effective | 2024-01-01 |
NCCI unit limits (MUE)
| Claim type | Max units per day | Rationale |
|---|---|---|
| DME suppliers | 360 | CMS Policy |
| outpatient hospital claims | 360 | Prescribing Information |
| practitioner claims | 360 | Prescribing Information |
What changed for J1105
- 2024-01-01: J1105 added to HCPCS Level II
- Next scheduled CMS quarterly update (HCPCS and DMEPOS fee schedule): 2027-01-01
Frequently asked questions
What is HCPCS code J1105?
J1105 is the HCPCS Level II code for dexmedetomidine, oral, 1 mcg. Short descriptor: "Dexmedetomidine film, 1 mcg".
Does Medicare cover J1105?
Coverage code I — Not payable by Medicare. Medicare does not pay separately under this code; another code applies.
How many units of J1105 can be billed per day?
360 on DME suppliers; 360 on outpatient hospital claims; 360 on practitioner claims (NCCI medically unlikely edits).
Related J11 codes
- J1100 — Injection, dexamethasone sodium phosphate, 1 mg
- J1110 — Injection, dihydroergotamine mesylate, per 1 mg
- J1120 — Injection, acetazolamide sodium, up to 500 mg
- J1130 — Injection, diclofenac sodium, 0.5 mg
- J1160 — Injection, digoxin, up to 0.5 mg
- J1162 — Injection, digoxin immune fab (ovine), per vial
- J1163 — Injection, diltiazem hydrochloride, 0.5 mg
- J1164 — Injection, diltiazem hydrochloride in 0.72% sodium chloride, 0.5 mg
- J1165 — Injection, phenytoin sodium, per 50 mg
- J1170 — Injection, hydromorphone, up to 4 mg
- J1171 — Injection, hydromorphone, 0.1 mg
- J1180 — Injection, dyphylline, up to 500 mg
Building a device that would bill under a code like this? Caduvo matches a device description to HCPCS/CPT codes, Medicare coverage and payment, and the FDA pathway in one report.
Next steps
- Run a reimbursement report for a device billed under J1105
- Watch J1105 for fee, coverage and descriptor changes
- Build a full Medicare revenue model for J1105
Compiled by Caduvo from public CMS (Medicare) records, HCPCS release October 2026. Fees are Medicare allowables, not commercial rates. Not reviewed or endorsed by CMS. Not billing or legal advice. Report an error. Data and corrections policy.